Drug
Desvenlafaxine Sustained Release
Desvenlafaxine Sustained Release: highest development phase Phase 1, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Desvenlafaxine Sustained Release (DVS SR) NCT00440427 | Phase 1 | Depressive Disorder, Major |
Latest
No recent events.
Follow Desvenlafaxine Sustained Release on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.